Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tiotropium on Exercise Tolerance in COPD
NCT02172300Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 1999
- Primary completion
- Nov 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jun 1999; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172300.